Detailed answers about PATIENT ADVOCATE CASE MANAGEMENT LIMITED, including incorporation, status, business activity, and accounts information.
When was PATIENT ADVOCATE CASE MANAGEMENT LIMITED founded?
PATIENT ADVOCATE CASE MANAGEMENT LIMITED was officially incorporated on 5 May 2023 and is registered under company number 14848871. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is PATIENT ADVOCATE CASE MANAGEMENT LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of PATIENT ADVOCATE CASE MANAGEMENT LIMITED?
PATIENT ADVOCATE CASE MANAGEMENT LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does PATIENT ADVOCATE CASE MANAGEMENT LIMITED do?
PATIENT ADVOCATE CASE MANAGEMENT LIMITED operates in the following sector: 78300 - Human resources provision and management of human resources functions. This provides insight into the company's primary business activity and industry focus.
What is PATIENT ADVOCATE CASE MANAGEMENT LIMITED's registered address?
The registered office address of PATIENT ADVOCATE CASE MANAGEMENT LIMITED is C/O UHY HACKER YOUNG THAMES HOUSE, ROMAN SQUARE, SITTINGBOURNE, KENT, UNITED KINGDOM, ME10 4BJ. This is the official address filed with Companies House for legal and statutory correspondence.
Is PATIENT ADVOCATE CASE MANAGEMENT LIMITED financially stable?
The most recent accounts for PATIENT ADVOCATE CASE MANAGEMENT LIMITED were made up to 31 December 2024, filed as TOTAL EXEMPTION FULL. Next accounts are due by 30 September 2026.